|
RU2586974C2
(ru)
*
|
2010-03-04 |
2016-06-10 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
|
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
|
GB201111704D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Novel compounds
|
|
JO3115B1
(ar)
|
2011-08-22 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مركبات بيريدازينون واستخدامها كمثبطات daao
|
|
US9212147B2
(en)
|
2011-11-15 |
2015-12-15 |
Takeda Pharmaceutical Company Limited |
Dihydroxy aromatic heterocyclic compound
|
|
TWI638802B
(zh)
*
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚ｏ－甲基轉移酶活性抑制化合物
|
|
CN103845317B
(zh)
*
|
2012-11-28 |
2018-05-08 |
北京生命科学研究所 |
恩他卡朋在预防或治疗肥胖等代谢综合征中的应用
|
|
GB201222711D0
(en)
|
2012-12-17 |
2013-01-30 |
Takeda Pharmaceutical |
Novel compounds
|
|
MX2015006437A
(es)
|
2012-12-27 |
2015-08-14 |
Hoffmann La Roche |
Inhibidores de la enzima catecol-o-metiltransferasa (comt).
|
|
WO2014151380A1
(en)
|
2013-03-15 |
2014-09-25 |
Janssen Pharmaceutica Nv |
1,2,6-substituted benzimidazoles as flap modulators
|
|
WO2014151367A1
(en)
|
2013-03-15 |
2014-09-25 |
Janssen Pharmaceutica Nv |
1,2,5-substituted benzimidazoles as flap modulators
|
|
CN103588702B
(zh)
*
|
2013-10-26 |
2016-01-06 |
浙江大学 |
N-取代苯基吡啶-4-酮衍生物及其制备和应用
|
|
US9988373B2
(en)
|
2013-12-26 |
2018-06-05 |
Shionogi & Co., Ltd. |
Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
|
|
WO2016123576A1
(en)
|
2015-01-30 |
2016-08-04 |
Lieber Institute For Brain Development |
Comt inhibiting methods and compositions
|
|
AU2016252686B2
(en)
|
2015-04-24 |
2019-03-14 |
Shionogi & Co., Ltd. |
6-membered heterocyclic derivative and pharmaceutical composition comprising same
|
|
EP3365340B1
(en)
|
2015-10-19 |
2022-08-10 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
HUE060680T2
(hu)
|
2015-11-19 |
2023-04-28 |
Incyte Corp |
Heterociklusos vegyületek mint immunmodulátorok
|
|
EP3380471B8
(en)
*
|
2015-11-25 |
2022-01-19 |
Lieber Institute Inc. DBA Lieber Institute For Brain Development |
Tetrahydro-8h-pyrido[1,2-a]pyrazine-8-ones as comt inhibitors for the treatment of neurodegenerative disorders
|
|
CN105481812B
(zh)
*
|
2015-11-30 |
2020-04-21 |
重庆天奕恒化科技有限公司 |
一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
|
|
MA44075A
(fr)
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
|
ES2844374T3
(es)
|
2015-12-22 |
2021-07-22 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
ES2906460T3
(es)
|
2016-05-06 |
2022-04-18 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
HUE060256T2
(hu)
|
2016-06-20 |
2023-02-28 |
Incyte Corp |
Heterociklusos vegyületek mint immunmodulátorok
|
|
EP3484866B1
(en)
|
2016-07-14 |
2022-09-07 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
MA46045A
(fr)
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
US11066409B2
(en)
|
2016-10-17 |
2021-07-20 |
Shionogi & Co., Ltd. |
Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same
|
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
UA127785C2
(uk)
|
2016-12-22 |
2024-01-03 |
Інсайт Корпорейшн |
ПОХІДНІ ТЕТРАГІДРОІМІДАЗО[4,5-c]ПІРИДИНУ, ЯКІ ВИКЛИКАЮТЬ ІНТЕРНАЛІЗАЦІЮ PD-L1
|
|
GEP20227428B
(en)
|
2016-12-22 |
2022-10-25 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
ES2899402T3
(es)
|
2016-12-22 |
2022-03-11 |
Incyte Corp |
Derivados de piridina como inmunomoduladores
|
|
CN110475775B
(zh)
|
2017-03-31 |
2023-05-09 |
富士胶片株式会社 |
4-吡啶酮化合物或其盐、包含4-吡啶酮化合物的药物组合物及剂
|
|
CN108191746B
(zh)
*
|
2018-02-02 |
2020-06-16 |
暨南大学 |
一种羟基吡啶酮类化合物及其制备方法与应用
|
|
FI4212529T3
(fi)
|
2018-03-30 |
2025-04-23 |
Incyte Corp |
Heterosyklisiä yhdisteitä immunomodulaattoreina
|
|
SMT202300127T1
(it)
|
2018-05-11 |
2023-05-12 |
Incyte Corp |
Derivati di tetraidro-imidazo[4,5-c]piridina come immunomodulatori di pd-l1
|
|
EP3876930A4
(en)
|
2018-11-07 |
2022-07-20 |
Dana-Farber Cancer Institute, Inc. |
BENZIMIDAZOLE DERIVATIVES AND AZA-BENZIMIDAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND THEIR USES
|
|
EP3877371A4
(en)
|
2018-11-07 |
2022-07-27 |
Dana-Farber Cancer Institute, Inc. |
IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES USED AS JANUS KINASE 2 INHIBITORS AND ASSOCIATED USES
|
|
US12415816B2
(en)
|
2018-11-07 |
2025-09-16 |
Dana-Farber Cancer Institute, Inc. |
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
US11753406B2
(en)
|
2019-08-09 |
2023-09-12 |
Incyte Corporation |
Salts of a PD-1/PD-L1 inhibitor
|
|
KR20220075382A
(ko)
|
2019-09-30 |
2022-06-08 |
인사이트 코포레이션 |
면역조절제로서의 피리도[3,2-d]피리미딘 화합물
|
|
KR20220101664A
(ko)
|
2019-11-11 |
2022-07-19 |
인사이트 코포레이션 |
Pd-1/pd-l1 억제제의 염 및 결정질 형태
|
|
CN111170936B
(zh)
*
|
2020-01-19 |
2021-01-01 |
杭州泽德医药科技有限公司 |
3,4-二羟基-n-(1’-苄基-2’-羟乙基)-2-甲基吡啶氯化物及制备和应用
|
|
WO2021226261A1
(en)
|
2020-05-06 |
2021-11-11 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
KR102377058B1
(ko)
|
2020-11-04 |
2022-03-22 |
경북대학교 산학협력단 |
니아스텔라 코리엔시스에서 유래한 카테콜 o-메틸 트렌스퍼라제 및 이의 변이체
|
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
|
IL302590A
(en)
|
2020-11-06 |
2023-07-01 |
Incyte Corp |
Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
|
|
WO2022099075A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Crystalline form of a pd-1/pd-l1 inhibitor
|
|
EP4267574B1
(en)
|
2020-12-23 |
2025-04-23 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
EP4373487A4
(en)
*
|
2021-07-19 |
2025-10-29 |
Baylor College Medicine |
CORONAVIRUS MAJOR PROTEASE INHIBITORS AND THEIR METHODS OF USE
|
|
WO2023086320A1
(en)
|
2021-11-09 |
2023-05-19 |
Ajax Therapeutics, Inc. |
Forms and compositions of inhibitors of jak2
|
|
JP7782035B2
(ja)
|
2021-11-09 |
2025-12-08 |
エイジャックス セラピューティクス， インコーポレイテッド |
Ｊａｋ２阻害剤としての６－ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール
|
|
CN114716366B
(zh)
*
|
2022-04-13 |
2023-12-26 |
浙江大学 |
3-羟基吡啶-4-酮类衍生物及在抑制肾细胞铁死亡中的应用
|
|
CN116947812B
(zh)
*
|
2023-06-30 |
2025-09-02 |
南京红太阳医药研究院有限公司 |
一种艾司奥美拉唑镁降解杂质的制备方法
|
|
WO2025257687A1
(en)
*
|
2024-06-11 |
2025-12-18 |
Universidade Do Porto |
Hydroxypyridinone compounds as inhibitors of catechol-o-methyltransferase
|